Newer Macrolides as Empiric Treatment for Acute Q Fever Infection

AUTOR(ES)

Gikas, Achilleas

FONTE

American Society for Microbiology

RESUMO

The effectiveness of newer macrolides in acute Q fever for 113 patients was recorded. The mean times to defervescence were 2.9 days for doxycycline and 3.3, 3.9, 3.9, and 6.4 days for clarithromycin, roxithromycin, erythromycin, and β-lactams, respectively (P < 0.01 for macrolides versus β-lactams). We conclude that macrolides may be an adequate empirical antibiotic therapy for acute Q fever.

Documentos Relacionados

• Use of Macrolides for Q Fever
• Treatment of Q fever.
• Immunoglobulin responses in acute Q fever.
• Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients.
• Comparison of PCR and Serology Assays for Early Diagnosis of Acute Q Fever